Toth Financial Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Toth Financial Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Buy	35 +30	+600%	+$999	﹤0.01%	808
2026 Q1	$151	Hold	5	–	–	﹤0.01%	883
2025 Q4	$157	Buy	+5	New	+$123	﹤0.01%	865

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Toth Financial Advisory's TEVA Position: Q2 2026 in Review

Toth Financial Advisory increased its Teva Pharmaceuticals (TEVA) stake by 600% in Q2 2026, buying an estimated $999 and bringing the position to 35 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

Toth Financial Advisory first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Toth Financial Advisory held 35 shares of Teva Pharmaceuticals worth $1.19K as of Q2 2026.
Toth Financial Advisory bought 30 Teva Pharmaceuticals shares in Q2 2026, an estimated $999.
Teva Pharmaceuticals made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #808 holding.
Toth Financial Advisory first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.